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A fundamental question in biology is how different signaling
pathways use common signaling proteins to attain different devel-
opmental outcomes. The yeast transcription factor Ste12 is
required in at least two distinct signaling processes, each regulated
by many of the same protein kinases. Whereas Ste12-Ste12
homodimers promote transcription of genes required for mating,
Ste12-Tec1 heterodimers activate genes required for invasive
growth.We report that Ste12 and Tec1 undergo covalent modifica-
tion by the ubiquitin-related modifier SUMO. Stimulation by mat-
ing pheromone promotes sumoylation of Ste12 and diminishes the
sumoylation of Tec1. In the absence of sumoylation Tec1 is more
rapidly degraded.We propose that pheromone-regulated sumoyla-
tion of Ste12 and Tec1 promotes a developmental switch from the
invasive to the mating differentiation program.
The budding yeast Saccharomyces cerevisiae can initiate distinct
developmental programs depending on the presence or absence of spe-
cific external cues. Mating is initiated when a and  haploid cell types
secrete and respond to cell type-specific pheromones acting through G
protein-coupled receptors; once activated, the a and  cells fuse to form
an a/ diploid cell. Invasive or filamentous growth occurs in nutrient-
poor conditions and is manifested by altered budding and formation of
long branching filaments, as well as increased adherence and invasion of
the substratum. Both developmental outcomes require activation of a
protein kinase cascade comprised of Ste20, Ste11, Ste7, and Fus3 orKss1
(1, 2).
Fus3 and Kss1 are mitogen-activated protein (MAP)2 kinases that
phosphorylate substrates required for signaling in both the mating and
invasive growth pathways. Phosphorylation of Ste12 promotes binding
to a specific DNA sequence called the pheromone-response element
(PRE) (3–6), where it initiates transcription of genes required for effi-
cient mating (7–9). Ste12 can also assemble with another transcription
factor, Tec1 (10–13). Ste12-Tec1 heterodimers bind cooperatively to a
distinct DNA sequence called the filamentation- and invasive-response
element (FRE) (10, 11) present in the promoter region of genes that
regulate invasive or pseudohyphal growth (9, 14). The kinase activity of
Kss1 increases filamentation, whereas the kinase activity of Fus3 sup-
presses filamentation (1, 8, 10, 15, 16). Both pathways are negatively
regulated by Ste12-binding proteins Dig1/Rst1 and Dig2/Rst2 (7,
17–19) as well as by Ste12 binding to the unphosphorylated and inactive
form of Kss1 (20).
Although the mechanisms of MAP kinase and transcription factor
activation are well established, less understood is how signaling path-
ways that share the same components attain different developmental
fates (21). Signal identity has been ascribed to differences in signal mag-
nitude, duration, and frequency (22), as well as to the scaffolded associ-
ation of protein kinase components (23). Even where such differences
have been documented, the kinase signals must still be interpreted by
nuclear transcription factors to initiate expression of a distinct set of
genes (9). Here we have shown that Ste12 and Tec1 are covalently mod-
ified by the small ubiquitin-related protein SUMO (Smt3 in yeast).
Although stimulation by mating pheromone promotes sumoylation of
Ste12, the same treatment inhibits sumoylation of Tec1 and the protein
is instead degraded. These findings suggest that pheromone-regulated
sumoylation of transcription factors underlies the developmental
switch from the invasive to the mating differentiation program.
EXPERIMENTAL PROCEDURES
Strains and Plasmids—Standard methods for the growth, mainte-
nance, and transformation of bacteria and for themanipulation of DNA
were used throughout. Details of plasmid construction are available
from the authors. Exceptwhere stated otherwise,TEC1 and STE12were
expressed from single copy plasmids using the native promoter.
Unless otherwise indicated, the S. cerevisiae strains used in this study
were BY4741 (MATa leu2 met15 his3 ura3) and BY4741-derived
mutants lacking SIZ1, SIZ2, FUS3, KSS1, or TEC1 (Research Genetics)
or containing the Schizosaccharomyces pombe his5 gene and a tandem
affinity purification (TAP) tag at STE12 orTEC1 (24). Analysis ofUBC9
was carried out in strains MHY500 (MATa his3-200 leu2-3,112
ura3-52 lys2-801 trp1-1 gal2) and MHY1620 (MHY500 LEU2::ubc9-1
ubc9::TRP1) (from M. Hochstrasser) maintained at the semipermis-
sive temperature of 24 °C. Protein turnover experiments were con-
ducted in strains Z1256 (MATa ade2-1 trp1-1 can1-100 leu2-3,112
his3-11,15 ura3), Z1783 (Z1256, 3MYC::TEC1) (from R. Young),
Z1783-fus3 (Z1783 fus3::G418r), and Z1783-kss1 (Z1783
kss1::G418r) (this study). The invasive growth and FRE reporter tran-
scription assays were performed in the 1278-based invasive strain
MLY218a (MATa leu2 ura3, from J. Heitman) and MLY2189a-tec1
(MLY218a, tec1::URA3) (this study).
Growth,Transcription,andDegradationBioassays—Thepheromone-
dependent growth inhibition (halo) and reporter-transcription assays
were conducted as described previously (25). Unless indicated other-
wise, the concentration of-factor was 3M, which is 10-fold above the
EC50 for transcriptional induction. To monitor the loss of Tec1 over
time, mid-log cell cultures were treated with -factor for 60 min, fol-
lowed by cycloheximide addition as described previously (26). Immu-
noprecipitations, 6.5% gel electrophoresis, and immunoblot analysis
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were carried out as described previously (26) using antibodies against
SUMO (from C. Hoege and S. Jentsch), Protein A (Sigma), FLAG
(Sigma), and ubiquitin (Sigma).
RESULTS
A long-standing question in cell regulation is how signaling pathways
that share component proteins can attain different developmental fates.
To address this question we investigated whether Ste12 or Tec1 is
covalently modified by the small ubiquitin-related protein SUMO
(Smt3 in yeast) and whether pheromone-regulated modification of
these signaling proteins could underlie the switch from the invasive
growth to mating differentiation transcription program. We focused
initially on sumoylation because it is a reversible modification known to
regulate the activity of nuclear transcription factors, co-activators, and
co-repressors (27, 28). In addition, mass spectrometry sequencing iden-
tified Ste12 as one of several hundred proteins that co-purify with Smt3,
making it a likely substrate for sumoylation (29).
Ste12, fused to a TAP tag (24), was immunopurified, resolved by gel
electrophoresis, and detected by immunoblotting. The antibodies
strongly recognized the native form of the protein (Fig. 1, A and B), as
well as additional species12 and 24 kDa larger than the native protein,
a difference corresponding to themolecularmass of one or two copies of
mature SUMO, respectively. The presence of multiple high molecular
mass species suggested that Ste12 undergoes sumoylation at two or
more sites. The larger forms of the protein were more abundant in cells
treated with-factor pheromone, were less abundant in amutant strain
lacking the E3 SUMO ligase SIZ1 (Fig. 1A), and were completely absent
in aubc9-1mutant strain deficient in SUMO-conjugating enzyme activ-
ity (Fig. 1B) (30). Ste12 alsomigratedmore slowly in the ubc9–1mutant
strain; however, this mobility shift did not appear to be pheromone
regulated. Moreover, the shift is too small to arise from addition of
ubiquitin or a ubiquitin-like modifier and may instead result from
another known modification such as phosphorylation (3–6, 31–33).
To confirm that Ste12 is sumoylated we immunopurified Ste12
tagged with the FLAG epitope. The higher molecular mass form of
Ste12 was recognized by SUMO antibodies and was again enriched by
FIGURE 1. Pheromone promotes sumoylation and activation of Ste12. A, whole cell lysates from wild-type BY4741 and isogenic siz1 or siz2 mutant cells containing integrated
TAP-tagged Ste12 were immunoprecipitated with IgG-Sepharose and detected by immunoblotting using anti-SUMO antibodies as indicated and as detailed under “Experimental
Procedures.” Note that TAP is recognized by any IgG and is therefore recognized by anti-SUMO antibodies. Molecular mass standards (kDa) are provided to the right of the panel. B,
immunoprecipitates were prepared as described in panel A except that a ubc9-1 mutant strain and the isogenic wild-type were used. The predominant band in each case is the
unmodified protein, whereas the two slower migrating bands are sumoylated Ste12. C, whole cell lysates from wild-type (WT) and isogenic fus3 or kss1 mutant cells containing
FLAG epitope-tagged Ste12 or the parent vector were immunoprecipitated with M2 anti-FLAG resin, and the modified form of Ste12 was detected using anti-SUMO antibodies (top
panel). Unmodified Ste12 was detected by immunoblotting of whole cell lysates using anti-FLAG antibodies (bottom panel) to show relative expression. Numbers under each lane
refer to the difference in band intensity relative to lane 1, as determined by scanning densitometry. D, transcription activity was measured in ste12 cells transformed with a plasmid
containing an invasive-specific PRE reporter (FUS1 promoter, lacZ reporter) and a plasmid expressing FLAG-tagged Ste12 or FLAG-Ste12 fused to SUMO (Smt3) and treated with the
indicated concentrations of -factor. E, the same cells as in panel D were assayed for growth arrest response following exposure to 45 g of -factor for 48 h. The same cells were
spotted onto solid YPD medium and after 2 days rubbed vigorously under a stream of water to detect invasive growth. F, the same cells as in panel D were analyzed by immuno-
blotting of whole cell lysates using anti-FLAG antibodies. Note that Ste12 tagged with the FLAG epitope (1 kDa) migrates faster than Ste12 tagged with TAP (20 kDa). Note also
that the strains used in panel B are deficient in KSS1 (data not shown) and for this reason are used only in this experiment to demonstrate that sumoylation requires UBC9.
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pheromone stimulation (Fig. 1C). The increase in sumoylation was pro-
portionately greater than the induction of Ste12 expression that is typ-
ically observed in pheromone-treated cells.Moreover, deletion of either
FUS3 or KSS1 dampened the effect of pheromone on Ste12 sumoyla-
tion, consistent with the partially overlapping function of the two
kinases in this pathway (1, 16, 34). Kss1 and Fus3 phosphorylatemany of
the same proteins but with distinct substrate specificities, and this pre-
sumably accounts for the differences in Ste12 sumoylation in the two
mutants (35). We conclude from these data that Ste12 is sumoylated
and that sumoylation is enhanced in response to pheromone
stimulation.
Ste12 binds to PREs present within the promoters of several genes
involved in mating. The promoter of the FUS1 gene contains multiple
PREs and has beenwidely used tomonitor pheromone-stimulated tran-
scription activity (25). Thus, a reporter consisting of the PRE promoter
fused to lacZ (-galactosidase) was used to determine how sumoylation
affects Ste12 function. Initially we attempted to block sumoylation in
Ste12 by substituting Arg for Lys-174 and Lys-409, the two residues that
most closely match the preferred sequence for sumoylation (-K-X-
D/E, where  is a hydrophobic residue andX is any residue) (36). How-
ever, neither mutation, tested alone or in combination, blocked the
pheromone-stimulated mobility shift, suggesting that one or more of
the other 42 Lys residues in Ste12 is modified (data not shown).We also
investigated how the pheromone response is altered in the ubc9mutant
strain. In this mutant PRE-lacZ induction was substantially reduced
relative to the wild-type, suggesting that sumoylation is required for full
Ste12 activity (data not shown). However, even though the PRE reporter
is highly specific for Ste12 activity, the ubc9mutant could havemultiple
effects that indirectly affect reporter transcription activity. As an alter-
native approach we examined PRE-lacZ activity in cells expressing a
SUMO-Ste12 fusion protein. Similar SUMO substrate fusions have
been used previously to show that sumoylation can diminish transcrip-
tion factor function (37–39). In the absence of pheromone, cells
expressing SUMO-Ste12 exhibited no change in basal lacZ activity, sug-
gesting that sumoylation of Ste12 is not sufficient to initiate new gene
transcription. In the presence of pheromone, however, cells expressing
SUMO-Ste12 exhibited a 2-fold increase in maximum transcription
activity (Fig. 1D). The SUMO-Ste12 fusion also increased the phero-
mone-mediated growth arrest response, as indicated by a larger zone of
growth inhibition surrounding a source of -factor (the response was
also more transient, as indicated by resumption of colony growth and
the formation of a turbid halo) (Fig. 1E). Finally, activation of themating
response by Ste12-SUMO resulted in a concomitant decrease in the
invasive growth response (Fig. 1E). Expression levels of the SUMO-
Ste12 fusion were not elevated compared with Ste12 (Fig. 1F). However,
whereas native Ste12 is only partially sumoylated after pheromone stim-
ulation, the SUMO-Ste12 fusion resembles a protein that is fully sumoy-
lated all the time, and this presumably accounts for the higher transcrip-
tion and growth arrest response compared with the native partially
sumoylated protein. Thus, sumoylation of Ste12 appears to confer a
gain-of-function phenotype, but transcription activity is still contingent
on stimulation by upstream components in the pathway.
We then considered whether Tec1 is also regulated by sumoylation.
As before, a FLAG-Tec1 fusion was immunopurified and probed by
immunoblotting with antibodies to FLAG as well as SUMO.Once again
we could detect multiple bands with the FLAG antibody, one corre-
sponding to nativeTec1 and a second corresponding toTec1 potentially
modified by sumoylation. The higher molecular mass species was also
detected using anti-SUMO-antibodies, and both bands were absent in
cells containing only the parent vector (Fig. 2A). Pheromone treatment
resulted in diminished expression and substantially diminished sumoy-
lation of Tec1 (Fig. 2B). The pheromone-dependent decrease in Tec1
sumoylation is in marked contrast to the pheromone-dependent
increase observed for Ste12.
FIGURE 2. Pheromone regulates sumoylation
and ubiquitination of Tec1. A, whole cell lysates
from tec1 cells transformed with FLAG-tagged
Tec1 or the parent vector were immunoprecipi-
tated with M2 anti-FLAG resin and subjected to
immunoblotting using anti-FLAG or anti-SUMO
antibodies. B, the same cells were transformed
with triple-FLAG-tagged Tec1, a Lys-54-Arg Tec1
mutant (Tec1K54R), or the parent vector and then
treated with -factor, lysed, immunoprecipitated
with M2 anti-FLAG resin, and subjected to immu-
noblotting using anti-FLAG or anti-SUMO antibod-
ies. Numbers under each lane refer to the differ-
ence in band intensity of Tec1 and SUMO-Tec1
(where visible) relative to lane 1, as determined by
scanning densitometry. ND, not determined. C,
the same cells as in panel B were spotted onto solid
YPD medium and after 2 days rubbed vigorously
under a stream of water to detect invasive growth.
D, transcription activity was measured in the same
cells transformed with a plasmid containing an
invasive-specific FRE reporter (TEC1 promoter,
lacZ reporter) or the mating-specific PRE reporter
described in Fig. 1.
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Because increased sumoylation promotes Ste12 activity we antici-
pated that decreased sumoylation might result in diminished Tec1
activity. To test this model we replaced a consensus site Lys at position
54 and found that it successfully eliminated detectable sumoylation
concomitant with higher overall expression levels (Fig. 2B). We then
measured invasive growth and transcription induction using a FRE pro-
moter fused to lacZ. Rather than decrease activity, the sumoylation-
deficient Tec1K54R mutant exhibited slightly elevated FRE-lacZ and
invasive growth activities (Fig. 2, C and D) (8, 40, 41). Together these
data reveal that sumoylation is not required for full Tec1 transcription
activity or proper regulation of invasive growth behavior.
The higher abundance of Tec1K54R could result from a loss of ubiq-
uitination. Ubiquitin attachment typically leads to rapid capture and
degradation of the substrate by the proteasome protease complex (27),
and it was recently documented that Tec1 undergoes phosphorylation-
dependent ubiquitination and accelerated degradation in pheromone-
stimulated cells (42–44). Moreover, modification by SUMO and ubiq-
uitin are often antagonistic and can sometimes occur on the same Lys
residue (45, 46). In agreement with this model, the unsumoylated
Tec1K54R mutant was ubiquitinated at a reduced level relative to the
wild-type protein (data not shown); the residual ubiquitination was
most likely due tomodification of an alternate site when the primary site
(Lys-54 in this case) becomes unavailable.Moreover, Tec1K54R accumu-
lates a prominent species with reduced mobility but that is not recog-
nized by the anti-SUMOantibodies (Fig. 2B); we presume that this band
is due to an accumulation of phosphorylated but poorly ubiquitinated
protein.
Tec1 ubiquitination is regulated by the MAP kinases Fus3 and Kss1
(42–44). These MAP kinases phosphorylate many common substrates
and have partially overlapping function in vivo. Expression of either
kinase is sufficient to partially sustain the mating response (Fig. 1C) (1,
16, 34). However, significant differences have been reported for the
invasive pathway. Deletion of KSS1 is sufficient to block invasive
growth, whereas deletion of FUS3 promotes invasive behavior. More-
over, deletion of FUS3 (but not KSS1) results in an increase in FRE
binding activity (9) and transcription of FRE-containing genes (8, 10,
16). To determine whether sumoylation might underlie these differ-
ences we compared Tec1 expression in fus3 and kss1mutant strains.
Deletion of FUS3 (but notKSS1) resulted in elevated expression of Tec1
and also of the sumoylated form of Tec1 (Fig. 3A). Moreover, phero-
mone treatment of the fus3 mutant strain no longer diminished, and
even increased slightly, the expression of Tec1. These differences in
expression could be ascribed to differences in protein stability because
Tec1 was degradedmore slowly in the absence of FUS3 expression (Fig.
3B) (42–44). Thus, the negative regulation of Tec1 abundance by Fus3
(but not Kss1) is fully concordant with the previously reported role of
Fus3 (but not Kss1) in FRE transcription and invasive growth behavior.
Stated differently, there is a strong correlation between Tec1 sumoyla-
tion, stability, expression, and transcription activity.
Finally, the relationship betweenTec1 sumoylation and abundance sug-
FIGURE 3. Regulation of Tec1 expression by Fus3. A, wild-type or isogenic fus3 or kss1 mutant cells containing integrated triple-Myc-tagged Tec1 were treated with -factor and
subjected to immunoblotting of whole cell lysates using anti-Myc antibodies as indicated. Numbers under each lane refer to the difference in band intensity of Tec1 and SUMO-Tec1
(where visible) relative to lane 3, as determined by scanning densitometry. ND, not determined. B, the same cells as in panel A were treated with -factor pheromone as indicated,
treated with cycloheximide for the indicated times to block new protein translation, and subjected to immunoblotting of whole cell lysates using anti-Myc antibodies. C, a long
exposure of an immunoblot from wild-type cells to show slower degradation of the sumoylated versus unmodified form of Tec1. Myc-tagged Tec1 was used for these experiments
to afford more sensitive detection of protein turnover by immunoblotting. Lower panel, band intensity as quantitated by densitometric scanning. D, whole cell lysates from tec1 cells
transformed with FLAG-tagged Tec1 expressed using the heterologous GAL1 promoter and treated with cycloheximide for the indicated times were immunoprecipitated with M2
anti-FLAG resin and subjected to immunoblotting using anti-FLAG or anti-SUMO antibodies.
Pheromone-regulated Sumoylation in Yeast
JANUARY 27, 2006 • VOLUME 281 • NUMBER 4 JOURNAL OF BIOLOGICAL CHEMISTRY 1967
gests that sumoylation might stabilize the protein. A prediction of this
model is that sumoylated Tec1 should degrade more slowly than the
unmodified protein. To test this, we compared the abundance of sumoy-
lated and non-sumoylated Tec1 over time, following cycloheximide treat-
ment to block new protein synthesis. As predicted, the sumoylated form of
the protein persisted much longer than the unmodified species, whether
expressed under the control of the native promoter (Fig. 3C) or a heterolo-
gous inducible promoter (fromGAL1, Fig. 3D).
DISCUSSION
Here we have demonstrated that the transcription factors Ste12 and
Tec1 are sumoylated. These are the first components of theMAP kinase
signaling cascade shown to undergo sumoylation in yeast. More signif-
icantly, sumoylation of both proteins is regulated by pheromone.
Whereas pheromone promotes sumoylation of Ste12, the same treat-
ment results in diminished sumoylation of Tec1.
With respect to Tec1, immunopurification experiments revealed a
marked reduction in the proportion of sumoylated protein following
treatment with -factor pheromone (Fig. 2B). Immunoblotting of
whole cell extracts also revealed a marked decrease in Tec1 abun-
dance (Fig. 3A) and accelerated Tec1 degradation (Fig. 3B) after
pheromone treatment. In contrast, cells lacking Fus3 exhibited no
pheromone-dependent change in Tec1 expression, sumoylation
(Fig. 3A), or stability (Fig. 3B). These data support a model in which
Tec1 is de-sumoylated and consequently degraded in response to
MAP kinase signaling.
Another function of sumoylation evidently is to regulate Tec1 ubiq-
uitination. Sumoylated Tec1 is more stable than the non-sumoylated
protein, and mutating the lysine residue used for sumoylation leads to
an increase in Tec1 abundance. The simplest explanation is that the
same lysine residue is used for both sumoylation and ubiquitination and
that sumoylation enhances protein stability by competing with ubiq-
uitin for a common target site. Tec1K54R is still partially ubiquitinated,
however, suggesting that other regulatorymechanisms could exist (data
not shown). For instance, sumoylationmight prevent recognition of the
protein by the proteolytic machinery and thus protect the protein from
degradation.
We also attempted to block Ste12 sumoylation by mutating the
two best candidate sites, alone and in combination. Unfortunately,
neither of those mutations blocked Ste12 sumoylation. Besides these
two residues, there are another 42 lysines in Ste12 that could poten-
tially serve as sites of sumoylation. Furthermore, it is possible that
mutating a preferred site leads to sumoylation at another cryptic site.
For these reasons we took an alternative approach and examined the
behavior of a SUMO-Ste12 fusion. The gain-of-function phenotype
exhibited by the fusion protein, together with the stimulus-depend-
ent nature of Ste12 sumoylation, supports the suggestion that
sumoylation promotes Ste12 activity. However, a rigorous test of this
aspect of the model will require that the sumoylation sites in Ste12 be
definitively mapped and mutated.
Tec1 is one of a small but growing list of signaling proteins that
undergo ubiquitination (42, 43), a list that in yeast includes pheromone
receptors (48, 49), the G protein  subunit Gpa1 (50, 51), the RGS
protein Sst2 (26), and the effector kinase Ste7 (52, 53). Ubiquitination of
Ste2, Ste7, and Sst2 are stimulated by pheromone and may therefore
contribute to feedback regulation of signaling. In contrast, pheromone-
regulated sumoylation of Ste12 and Tec1 is less likely to regulate signal
intensity but rather signal specificity by favoring activation of the mat-
ing pathway and inactivation of the invasive growth pathway. Given the
prevalence of transcription factors that are both sumoylated and ubiq-
uitinated, and of signaling pathways that use shared MAP kinase com-
ponents, the mechanisms established here are likely to be recapitulated
in other signaling systems.
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